NDC 68071-5068-06 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-5068
- Requested NDC
- 68071-5068-06
- Package NDCs from labels
- 68071-5068-6, 68071-5068-06
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-06-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Tablets USP CIV | NuCare Pharmaceuticals,Inc. | 2024-06-19 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5068-6 | 2021-02-19 | C162847 | 48780-1 | ba0f9c33-27fa-a910-e053-dadaa90a0b85 | Lorazepam Tablets USP CIV |
| 68071-5068-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-27fa-a910-e053-dadaa90a0b85 | Lorazepam Tablets USP CIV |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5068-6 | Lorazepam | 6 in 1 BOTTLE | TABLET | 6 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5068 | LORAZEPAM TABLET [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240621_933b5ef3-ec29-1a96-e053-2995a90a2d33.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | b79b38ee-c29d-4099-964f-000031f47f5a | 2022-04-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1c956cc1-9217-46e0-80a3-7c811163d3f1 | 2021-09-30 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | 5ff82103-cc57-4af9-9362-82a7c686271d | 2021-03-31 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | a4fa14be-cef1-4b4b-b099-abde92f15145 | 2019-01-08 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 08bd30b0-a1c1-4ec3-bb9c-b1d55ac59f75 | 2018-11-05 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.